ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of a single cell-based signature for predicting prognosis risk and immunotherapy response in patients with glioblastoma

Dai, Ziyu; Zhang, Nan; Zhou, Ran; Zhang, Hao; Zhang, Liyang; Wang, Zeyu; Zeng, Wenjing; Luo, Peng; Zhang, Jian; Liu, Zhixiong*; Cheng, Quan*南方医科大学; 哈尔滨医科大学
Clinical Immunology2023-6DOI: 10.1016/j.clim.2023.109345
1被引5阅读
引用收藏
分享

摘要

This study constructed a novel gene pair signature based on bulk and single-cell sequencing samples in relative expression order within the samples. The subsequent analysis included glioma samples from Xiangya Hospital. Gene pair signatures possessed a solid ability to predict the prognosis of glioblastoma and pan-cancer. Samples having different malignant biological hallmarks were distinguished by the algorithm, with the high gene pair score group featuring classic copy number variations, oncogenic mutations, and extensive hypomethylation, mediating poor prognosis. The increased gene pair score group with a poorer prognosis demonstrated significant enrichment in tumor and immune-related signaling pathways while presenting immunological diversity. The remarkable infiltration of M2 macrophages in the high gene pair score group was validated by multiplex immunofluorescence, suggesting that combination therapies targeting adaptive and innate immunity may serve as a therapeutic option. Overall, a gene pair signature applicable to predict prognosis hopefully provides a reference to guide clinical practice.

学科与关键词

关键词
Prognostic signatureGlioblastomaPan-cancerTumor immunotherapySingle-cell RNA sequencing
相关
加载中…
  • Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
    Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng*Frontiers in Genetics, 2022, 13: 899125.被引 2
  • A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma
    Fan, Wenhua; Wang, Di; Li, Guanzhang; Xu, Jianbao; Ren, Changyuan; Sun, Zhiyan; Wang, Zhiliang; Ma, Wenping; Zhao, Zheng; Bao, Zhaoshi; Jiang, Tao*; Zhang, Ying*CNS Neuroscience & Therapeutics, 2022, 28(12): 2090-2103.
  • Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
    Ji, Hang; Zhao, Hongtao; Jin, Jiaqi; Liu, Zhihui; Gao, Xin; Wang, Fang; Dong, Jiawei; Yan, Xiuwei; Zhang, Jiheng; Wang, Nan; Du, Jianyang*; Hu, Shaoshan*Frontiers in Genetics, 2022, 12: 736187.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Clinical Immunology
发表日期
2023-06
卷期
第 251 卷
页码
109345
DOI
10.1016/j.clim.2023.109345
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82073893, 82,172,685]; Hunan Provincial Natural Science Foundation of China [2022JJ20095]; Hunan Provincial Health Committee Foundation of China [202204044869]; High Performance Computing Center of Central South University

作者

  • D

    Dai, Ziyu (第一作者)

  • Z

    Zhang, Nan

    harbin med univ

查看全部 11 位作者收起作者
  • Z

    Zhou, Ran

  • Z

    Zhang, Hao

  • Z

    Zhang, Liyang

  • W

    Wang, Zeyu

  • Z

    Zeng, Wenjing

  • L

    Luo, Peng

    southern med univ

  • Z

    Zhang, Jian

    southern med univ

  • L

    Liu, Zhixiong (通讯)

  • C

    Cheng, Quan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417